<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01849601</url>
  </required_header>
  <id_info>
    <org_study_id>acotec-01</org_study_id>
    <nct_id>NCT01849601</nct_id>
  </id_info>
  <brief_title>Effectiveness and Safety Study of Peripheral Balloon Dilatation Catheter in Percutaneous Transluminal Angioplasty(PTA) Procedure</brief_title>
  <official_title>A Prospective, Multicenter and Single-arm Target Value Clinical Study on the Efficacy and Safety of Peripheral Balloon Dilatation Catheter in PTA Procedure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Acotec Scientific Co., Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Acotec Scientific Co., Ltd</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the peripheral balloon dilatation catheter
      (trade name: Iris) is safe an effective in PTA procedure.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>technical success rate of PTA procedure</measure>
    <time_frame>instant</time_frame>
    <description>successfully pass lesion(s)
successfully dilate lesion(s)( diameter of balloon reach at least 90% of the nominal diameter)
successfully retrieve
The definition of technical success rate of PTA procedure is that, all of the above 3 point are successful</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>safety assessment</measure>
    <time_frame>day 2 to day 10 after procedure or hospital discharge</time_frame>
    <description>relevant balloon complications occurred during procedure(failure of balloon inflation, rupture of the balloon, failure of balloon deflation, failure of withdrawn, catheter fracture, etc.).
Relevant major vascular complications occurred during procedure (rupture of blood vessels and acute vascular occlusion caused by dilation).</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">167</enrollment>
  <condition>Peripheral Arterial Disease</condition>
  <arm_group>
    <arm_group_label>PTA catheter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>percutaneous transluminal angioplasty balloon catheter</intervention_name>
    <arm_group_label>PTA catheter</arm_group_label>
    <other_name>PTA catheter</other_name>
    <other_name>trade name: Iris</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age: 18 yrs - 80 yrs.

          -  patients with iliac and / or femoral artery atherosclerotic lesions

          -  Rutherford grade of 1-5;

          -  Target lesion stenosisâ‰¥70% (visual estimation) (proportion of Trans-Atlantic
             Inter-Society Consensus(TASC) B, C and D grade lesions not less than 60% )

          -  Patients being able to understand the purpose of the test, and being volunteered to
             participate in and sign the informed consent.

        Exclusion Criteria:

          -  Patients not suitable for receiving interventional surgeries of lower limb arteries
             for treatment;

          -  Patients require intervention of lesions besides unilateral iliac and femoral artery
             lesions at the same time;

          -  Patients have been involved in clinical trials of other drugs or medical devices
             within the past three months;

          -  Patient is unable or unwilling to participate in this trial;

          -  Patients with serious heart and brain, liver and other vital organs failure;

          -  Patients with life expectancy less than 6 months;

          -  Pregnant women.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Wei Guo</name>
      <address>
        <city>Beijing</city>
        <zip>100853</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 28, 2013</study_first_submitted>
  <study_first_submitted_qc>May 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 8, 2013</study_first_posted>
  <last_update_submitted>March 19, 2015</last_update_submitted>
  <last_update_submitted_qc>March 19, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 23, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

